65,437 trials
Prostate Cancer
Primary: Number of Participants With Testosterone <0.5 Nanogram/Milliliter — 38; 32; 27; 38 participants
Influenza
Primary: Solicited Injection Site and Solicited Systemic Reactions Post-vaccination. — 62; 57; 0; 9 Participants
Influenza
Primary: Percentage of Participants With Solicited Injection Site or Systemic Reaction(s) After Fluzone® Vaccination — 78; 38; 78; 30 Percentage of Participants
Attention Deficit Hyperactivity Disorder
Primary: Change From Pre-dose (0 hr [Hour]) on the Swanson, Kotkin, Agler, M-Flynn & Pelham (SKAMP) Rating Scale Combined Score at 0.5 Hour During the 8- Hour Laboratory…
Epilepsy
Primary: Change in Number of Seizures After Conversion To Valproate Retard Minitablets Once Daily
Ovarian Cancer
Primary: Best Overall Tumor Response — 6; 25; 10; 5 participants
Dyslipidemia · Coronary Heart Disease · Mixed Dyslipidemia
Primary: Mean Percent Change in Triglycerides From Baseline to Final Visit — -47.1; -42.9; -32.6; -24.4 percent change — p=<0.001
Latent Tuberculosis Infection · Tuberculosis
Primary: VAS Pain Score (Visual Analogic Scale, That Ranges From 0 to 100) to Evaluate Each Volunteer Subjective Pain Intensity at the Inoculation Point
Mixed Dyslipidemia · Coronary Heart Disease · Dyslipidemia
Primary: Mean Percent Change in Triglycerides From Baseline to Final Visit — -45.6; -42.1; -29.6; -16.5 percent change — p=<0.001
Diabetes Mellitus, Type 2 · Insomnia
Primary: Sleep Efficiency — 79.5; 83.1 Percentage of time asleep — p=0.04
Influenza
Primary: Geometric Mean Titer (GMT) of Hemagglutination Inhibition Antibodies Pre-vaccination and 14 Days Post-vaccination — 5.0; 8.2; 187.8; 95.1 Titer
Non Small Cell Lung Cancer
Primary: Tumor Response at End of Treatment — 1; 18; 3; 1 participants
Dyslipidemia · Coronary Heart Disease · Mixed Dyslipidemia
Primary: Mean Percent Change in Triglycerides From Baseline to Final Visit — -37.4; -42.7; -31.7; -14.2 percent change — p=<0.001
Snake Bite · Blood Coagulation Disorders
Primary: Detection of Plasma Venom Levels During the Post Acute Treatment Period. — 0; 4; 6; 2 participants
Bipolar Disorder
Primary: Change in Montgomery-Asberg Depression Rating Scale (MADRS)Total Score — -6.07; -7.66; -5.75; -10.12 score on scale — p=0.6409